Myristic acid analogs are inhibitors of Junin virus replication

Microbes and Infection

Volumn 1, Issue 8, 1999, Pages 609-614

  Cordo, Sandra M ^a   Candurra, Nélida A ^a   Damonte, Elsa B ^a  

^a Laboratorio de Virologia Ciudad Autonoma de Buenos Aires   (Argentina)

Author keywords

Antiviral agents; Arenavirus; Glycoprotein; Junin virus; Myristic acid analogs; Myristoylation

Indexed keywords

ANTIVIRUS AGENT; MYRISTIC ACID DERIVATIVE; PROTEIN N MYRISTOYLTRANSFERASE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL VIABILITY; DRUG EFFECT; IMMUNOFLUORESCENCE TEST; JUNIN VIRUS; MYRISTYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMALIA; ARENAVIRUS; JUNIN VIRUS; RNA VIRUSES;

EID: 0032697710     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(99)80060-4     Document Type: Article

References (26)

1. Boutin J.A. Myristoylation. Cell Signal. 9:1997;15-35.
2. Bryant M.L., Ratner L., Duronio R.J., Kishore N.S., Devadas B., Adams S.P., Gordon J.I. Incorporation of 12-methoxydodecanoate into the human immunodeficiency virus 1 gag polyprotein precursor inhibits its proteolytic processing and virus production in a chronically infected human lymphoid cell line. Proc. Natl. Acad. Sci. USA. 88:1991;2055-2059.
3. Candurra N.A., Damonte E.B. Effect of inhibitors of the intracellular exocytic pathway on glycoprotein processing and maturation of Junin virus. Arch. Virol. 142:1997;2179-2193.
4. Conti G., Potincasa P., Chezzi C. Cerulenin inhibits production of mature virion particles in chick embryo fibroblasts infected by influenza A viruses. Res. Virol. 146:1995;141-149.
5. Contigiani M.S., Sabattini M.S. Virulencia diferencial de cepas de virus Junín por marcadores biológicos en ratones y cobayos. Medicina (Bs. As.). 37:1977;244-251.
6. Damonte E.B., Mersich S.E., Candurra N.A. Intracellular processing and transport of Junin virus glycoproteins influences virion infectivity. Virus Res. 34:1994;317-326.
7. Enria D.A., Briggiler A.M., Levis S.C., Vallejos D., Maiztegui J.I., Canonico P.G. Preliminary report: tolerance and antiviral effect of ribavirin in patients with Argentine hemorrhagic fever. Antiviral Res. 7:1987;353-359.
8. Fackler O.T., Kienzle N., Kremmer E., Boese A., Schramm B., Klimkait T., Kucherer C., Mueller-Lantzsch N. Association of human immunodeficiency virus Nef protein with actin is myristoylation dependent and influences its subcellular localization. Eur. J. Biochem. 247:1997;843-851.
9. Gilbert R.L., Blunt C.J., Harper D.R., Jeffries D.J., McIlhinney R.A.J. Effect of inhibitors of protein myristoylation on varicella-zoster virus replication. Antiviral Chem. Chemother. 5:1994;182-186.
10. Gottlinger H.G., Sodroski J.G., Hasetine W.A. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA. 86:1989;5781-5785.
11. Harper D.R., Gilbert R.L., Blunt C., McIlhinney J. Inhibition of varicella-zoster virus replication by an inhibitor of protein myristoylation. J. Gen. Virol. 74:1993;1181-1184.
12. Harper D.R., Gilbert R.L., O'Connor T.J., Kinchington D., Mahmood N., McIlhinney R.A.J., Jeffries D.J. Antiviral activity of 2-hydroxy fatty acids. Antiviral Chem. Chemother. 7:1996;138-141.
13. Hruby D.E., Franke C.A. Viral acylproteins: greasing the wheels of assembly. Trends Microbiol. 1:1993;20-25.
14. Johnson D.R., Cox A.D., Solski P.A., Devadas B., Adams S.P., Leimgruber R.M., Heuckeroth R.O., Buss J.E., Gordon J.I. Functional analysis of protein N-myristoylation metabolic labeling studies using three oxygen-substituted analogs of myristic acid and cultured mammalian cells provide evidence for protein-sequence-specific redistribution. Proc. Natl. Acad. Sci. USA. 87:1990;8511-8515.
15. McKee K.T., Huggins J.W., Trahan C.J., Mahlandt B.G. Ribavirin prophylaxis and therapy for experimental Argentine hemorrhagic fever. Antimicrob. Agents Chemother. 32:1988;1304-1309.
16. Moscufo N., Simons J., Chow M. Myristoylation is important at multiple stages in poliovirus assembly. J. Virol. 65:1991;2372-2380.
17. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 65:1983;55-63.
18. Paige L.A., Guo Q.Z., deFrees S.A., Cassady J.M., Geahlen R.L. Metabolic activation of 2-substituted derivatives of myristic acid to form potent inhibitors of myristoyl-CoA:Protein N-myristoyl transferase. Biochemistry. 29:1990;10566-10573.
19. Parang K., Wiebe L.I. Jr, Knaus E.E., Huang J.S., Tyrrell D.L., Czismadia F. In vitro antiviral activities of myristic acid analogs against human immunodeficiency and hepatitis B viruses. Antiviral Res. 34:1997;75-90.
20. Parodi A.S., Greenway D.J., Ruggiero H.R., Rivero S., Frigerio M.J., d, e laBarrera M., Mettler N., Garzón F., Boxaca M., Guerrero L.B., Nota N.R. Sobre la etiología del brote epidémico de Junín. El Día Médico. 30:1958;2300-2301.
21. Prange R., Clemen A., Streeck R.E. Myristylation is involved in intracellular retention of hepatitis B virus envelope proteins. J. Virol. 65:1991;3919-3923.
22. Romanowski V. Genetic organization of Junin virus the etiological agent of Argentine hemorrhagic fever. Salvato M.S. The Arenaviridae. 1993;51-101 Plenum Press, New York.
23. Sanchez A., Pifat D., Kenyon R.H., Peters C.J., McCormick J.B., Kiley M.P. Junin virus monoclonal antibodies: characterization and cross-reactivity with other arenaviruses. J. Gen. Virol. 70:1989;1125-1132.
24. Schlesinger M.J., Malfer C. Cerulenin blocks fatty acid acylation of glycoproteins and inhibits vesicular stomatitis and Sindbis virus particle formation. J. Biol. Chem. 255:1982;9887-9890.
25. Towler D.A., Gordon J.I., Adams S.P., Glaser L. The biology and enzymology of eukaryotic protein acylation. Ann. Rev. Biochem. 57:1988;69-99.
26. Weissenbacher M.C., Laguens R.P., Coto C.E. Argentine hemorrhagic fever. Curr. Top. Microbiol. Immunol. 134:1987;79-116.